Nurix Therapeutics, Inc. Balance Sheet
NRIX / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Nurix Therapeutics, Inc. had $688M in total assets and $539M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $247.0M | $110.0M | $54.6M | $64.5M | $80.5M | $119.4M | $34.8M |
| Current Assets | $606.8M | $619.4M | $295.5M | $318.4M | $311.1M | $298.4M | $39.4M |
| PP&E (Net) | $22.5M | $17.8M | $16.8M | $17.2M | $11.3M | $6.7M | $3.9M |
| Total Assets | $688.1M | $669.3M | $355.6M | $416.8M | $476.8M | $396.3M | $44.0M |
| Current Liabilities | $86.5M | $95.9M | $87.0M | $70.7M | $66.3M | $44.5M | $16.1M |
| Shareholders' Equity | $538.7M | $527.0M | $200.5M | $342.3M | $290.3M | $290.3M | -$57.7M |